The CHEMSAS Promise
  advanced molecular screening
     
  novel activity mapping
     
  customized solutions
     
CHEMSAS Performance
     
  anti-hiv
     
  anti-cancer
     
  anti-arrhythmic
     
  anti-hypertensive
     
  anti-microbial
     
  glossary

 

 

The Hybrid ANN Model: Cross Validated Results

Correctly classified 1398 of 1400 (99.86%), chemical structures with respect to known in vitro activity against HIV1 (Table 1).
Sensitivity, Specificity and Predictive Values were all >99%
The area under the receiver operator curve (ROC) for the hybrid model was 0.978

Anti-HIV 2 x 2 Table
 
Active
Inactive
Active 573 2
Inactive 0 825
Analysis
Positive Predicitve Value 99.65%
Negative Predictive Value 100%
Sensitivity 100%
Specificity 99.76%
Area Under ROC 0.978%

 

N=1400 molecules; 573 Active and 827 Inactive against HIV in vitro

Active Inactive PPV NPV

Active 573 2 99.65%

Inactive 0 825 100%

Sensitivity 100%
Specificity 99.76%
Area under ROC = 0.978



 

 

Critical Outcome Technologies Inc., © 2000-2001. All rights reserved.